In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...
More »SEARCH RESULT
Total Matching Records found : 1504
RTI activist asked to pay Rs 1.29 lakh for information-Kiran Sonawane
Right to Information (RTI) activist Sanjay Bhaklika has alleged that the Adharwadi prison authorities demanded Rs 1.29 lakh from him for 12,500 pages of information on the jail. Bhaklika, 40, a resident of Sai Chowk, Kadakpada in Kalyan, said, “I was in jail for 43 days on a false forgery case. During my time inside the prison, I saw many irregularities. So, after getting released on bail, I decided to expose...
More »Novartis vs India: the showdown approaches by Simon Reid-Henry
The Swiss-based pharmaceutical giant Novartis is taking the state of India to court in a case that has, after rumbling about in the lower courts for six years, wound up as a very public litmus test of the legal framework sustaining India’s generic drugs revolution. With the case due before the Supreme Court on 28 March, the fate of millions who depend on affordable Indian medicines may soon hang in the...
More »New approach to Nrega as it runs out of steam
-Rediff.com Even while the UPA Government is pushing for two more flagship programmes of food for all and medicines to all, its first flagship programme of the Mahatma Gandhi National Rural Employment Guarantee Act (Nrega) is losing steam. More than 40 per cent of the Rs 40,000-crore (Rs 400 billion) budget sanctioned for it during 2011-12 remained unspent until December, prompting the Finance Ministry to propose a reduced budget for it in...
More »UN updates guidelines on joint AIDS-tuberculosis treatment to save more lives
-The United Nations An estimated 910, 000 lives were saved globally in six years due to guidelines intended to ensure that people living with HIV/AIDS are protected from tuberculosis, the United Nations World Health Organization (WHO) said today, releasing an updated policy on joint prevention, diagnosis and treatment of both diseases. TB is a leading cause of death among people living with HIV/AIDS, which weakens the immune system, making those infected much...
More »
